Viewing Study NCT00073892


Ignite Creation Date: 2025-12-24 @ 3:23 PM
Ignite Modification Date: 2026-02-05 @ 7:34 AM
Study NCT ID: NCT00073892
Status: COMPLETED
Last Update Posted: 2022-06-27
First Post: 2003-12-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PI-88 in Treating Patients With an Advanced Malignancy (Cancer) or Stage IV Melanoma
Sponsor: Cellxpert Biotechnology Corp.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma (Skin) View
None Unspecified Adult Solid Tumor, Protocol Specific View
Keywords:

Keywords

Keyword Brief Keyword Text View
None unspecified adult solid tumor, protocol specific View
None stage IV melanoma View
None recurrent melanoma View